Using various models of increased vascular permeability (turpentine-induced pleurisy, kaolin-, glass and carrageenin-elicited paw oedema) it was shown that benzoctamine is capable of antagonizing the permeability disturbances occurring in the early phase of inflammatory reactions. The compound does not exert an anti-arthritic action.